Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder

Urology Annals

Volumn 3, Issue 3, 2011, Pages 127-132

  Ali El Dein, Bedeir ^a   Al Marhoon, Mohammed S ^a   Abdel Latif, Mohamed ^a   Mesbah, Ahmed ^a   Shaaban, Atallah A ^a   Nabeeh, Adel ^a   Ibrahiem, El Housseiny I ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Cystectomy; deferred; non muscle invasive bladder cancer; primary

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CYSTECTOMY; DEFERRED CYSTECTOMY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NONMUSCLE INVASIVE BLADDER CANCER; PRIMARY CYSTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT FAILURE;

EID: 80053081007     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.84960     Document Type: Article

References (26)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-48. (Pubitemid 28550639)
2. Sylvester RJ, van der MEIJDEN AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77.
3. Althausen AF, Prout GR, Jr, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976;116:575-80.
4. Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP Jr. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004;22:290-4. (Pubitemid 38996784)
5. Nieder AM, Soloway MS. Eliminate the term "superficial" bladder cancer. J Urol 2006;175:417-8. (Pubitemid 43067314)
6. Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 2001;166:1296-9. (Pubitemid 32862159)
7. Smith JA Jr, Labasky RF, Cockett AT, Fracchia JA, Montie JE, Rowland RG. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. J Urol 1999;162:1697-701. (Pubitemid 29474702)
8. Stockle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R. Radical cystectomy-often too late? Eur Urol 1987;13:361-7.
9. Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: Do risk factors define feasibility of bladder-sparing approach? Eur Urol 2008;53:146-52. (Pubitemid 350166714)
10. Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 2004;172:70-5. (Pubitemid 41615041)
11. Ali-El-Dein B, Nabeeh A, Ismail E, Ghoneim MA. Sequential bacillus Calmette-Guérin and epirubicin versus bacillus Calmette-Gurin alone for superficial bladder tumors: A randomized prospective study. J Urol 1999;162:339-42. (Pubitemid 29434336)
12. Volkmer B, Hautmann R, Gschwend J. Early versus late cystectomy for T1G3 transitional cell carcinoma (TCC) of the bladder. Eur Urol Suppl 2006;5:24 (abstract no. 5).
13. Malavaud B. T1G3 bladder tumours: The case for radical cystectomy. Eur Urol 2004;45:406-10. (Pubitemid 38376195)
14. Chang SS, Cookson MS. Radical cystectomy for bladder cancer: the case for early intervention. Urol Clin North Am 2005;32:147-55. (Pubitemid 40603289)
15. Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN. Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology 2002;59:227-31. (Pubitemid 34134520)
16. Huguet J, Crego M, Sabate S, Salvador J, Palou J, Villavicencio H. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: Pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 2005;48:53-9. (Pubitemid 40838628)
17. Bui TT, Schellhammer PF. Additional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response. Urology 1997;49:687-90.
18. Jakse G, Hall R, Bono A, Holtl W, Carpentier P, Spaander JP, et al. Intravesical BCG in patients with carcinoma in situ of the urinary bladder: Long-term results of EORTC GU Group phase II protocol 30861. Eur Urol 2001;40:144-50. (Pubitemid 32786100)
19. Corrigan NT, Crooks J, Shand J. Are dedicated bladder films necessary as part of intravenous urography for haematuria? BJU Int 2000;85:806-10. (Pubitemid 30242782)
20. Catalona WJ, Hudson MA, Gillen DP, Andriole GL, Ratliff TL. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. J Urol 1987;137:220-4. (Pubitemid 17016634)
21. Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C. Guidelines on bladder cancer. Eur Urol 2002;41:105-12. (Pubitemid 35428874)
22. Solsona E, Iborra I, Dumont R, Rubio-Briones J, Casanova J, Almenar S. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 2000;164:685-9. (Pubitemid 30637602)
23. Joudi FN, O'Donnell MA. Second-line intravesical therapy versus cystectomy for bacille Calmette-Guerin (BCG) failures. Curr Opin Urol 2004;14:271-5. (Pubitemid 39141983)
24. Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Optimal management of high-risk T1G3 bladder cancer: A decision analysis. PLoS Med 2007;4:e284.
25. Sengupta S, Blute ML. The management of superficial transitional cell carcinoma of the bladder. Urology 2006;67:48-54.
26. Joudi FN, Smith BJ, O'Donnell MA, Konety BR. Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Urology 2003;62:1083-8. (Pubitemid 37510096)